PRA was selected to perform a Phase II colorectal cancer trial due to our knowledge from previous colorectal studies as well as our evidence-based approach. In only a few months, our new client experienced PRA’s commitment open communication and engaging relationships and our determination to meet critical deadlines. These qualities are now the foundation of our very successful partnership.
Persistence Leads To High Enrollment
A Phase IV, randomized, single-blind, placebo-controlled, multi-center study to evaluate the immunogenicity of pneumococcal and influenza vaccines in…
PRA Successfully Delivers A Complex Phase I Psoriasis Study
Exceptional Support and Innovative Strategies Combat Study Challenges.
We’re in the business of improving lives, but drug development isn’t the only way we’re doing it. While bringing new treatments to market is…